SUMOCOR, LLC
Biotech · Defunct
Small molecule therapeutic (N106 and analogs) that activates SUMO E1 ligase to increase SUMOylation of SERCA2a cardiac calcium pump
- Grants
- $1.4M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Small Molecule Therapy for the Treatment of Heart Failure | $550,612 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing Small Molecule Therapies for Heart Failure | $315,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Small Molecule Therapy for the Treatment of Heart Failure | $268,206 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel SUMO Activators for the Treatment of Duchenne Muscular Dystrophy-Associated Heart Failure | $240,751 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2573 | Biosceptre International Ltd | — | $1.0M |
| 2574 | MATINAS BIOPHARMA, INC. | — | $1.0M |
| 2575 | CURIS INC | — | $964K |
| 2576 | SUMOCOR, LLC | — | — |
| 2577 | Thiogenesis Therapeutics, Corp. | — | $878K |
| 2578 | Gradient Pharmaceuticals, Inc. | — | $850K |
| 2579 | Chemistry Holdings, Inc. | — | $845K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.